Get the full Ploot company profile
Access contacts, investors, buying signals & more
Ploot has raised $447K in seed funding. The Spanish-language startup makes software for creating LinkedIn content, built around helping people write and analyze their posts to strengthen their personal brand.
The company says it has spent months studying top content creators on LinkedIn to build tools aimed at newer creators and established experts alike - the pitch being more authority, a sharper personal brand, and posts people actually remember. No investors were disclosed.
Valencia's Ploot raises €400K seed to challenge cold outbound sales - Dealroom Before you continue EN English United States Deutsch English Español Français Italiano All languages Afrikaans azərbaycan bosanski català Čeština Cymraeg Dansk Deutsch eesti English United Kingdom Español España Español Latinoamérica euskara Filipino Français Canada Français France Gaeilge galego Hrvatski Indonesia isiZulu íslenska Italiano Kiswahili latviešu lietuvių magyar Melayu Nederlands norsk o‘zbek polski Português Brasil Português Portugal română shqip Slovenčina slovenščina srpski (latinica) Suomi Svenska Tiếng Việt Türkçe Ελληνικά беларуская български кыргызча қазақ тілі македонски монгол Русский српски Українська ქართული հայերեն עברית اردو العربية فارسی አማርኛ नेपाली मराठी हिन्दी অসমীয়া বাংলা ਪੰਜਾਬੀ ગુજરાતી ଓଡ଼ିଆ தமிழ் తెలుగు ಕನ್ನಡ മലയാളം සිංහල ไทย ລາວ မြန်မာ ខ្មែរ 한국어 日本語 简体中文 繁體中文 繁體中文 香港 Sign in EN English United States Deutsch English Español Français Italiano All languages Afrikaans azərbaycan bosanski català Čeština Cymraeg Dansk Deutsch eesti English United Kingdom Español España Español Latinoamérica euskara Filipino Français Canada Français France Gaeilge galego Hrvatski Indonesia isiZulu íslenska Italiano Kiswahili latviešu lietuvių magyar Melayu Nederlands norsk o‘zbek polski Português Brasil Português Portugal română shqip Slovenčina slovenščina srpski (latinica) Suomi Svenska Tiếng Việt Türkçe Ελληνικά беларуская български кыргызча қазақ тілі македонски монгол Русский српски Українська ქართული հայերեն עברית اردو العربية فارسی አማርኛ नेपाली मराठी हिन्दी অসমীয়া বাংলা ਪੰਜਾਬੀ ગુજરાતી ଓଡ଼ିଆ தமிழ் తెలుగు ಕನ್ನಡ മലയാളം සිංහල ไทย ລາວ မြန်မာ ខ្មែរ 한국어 日本語 简体中文 繁體中文 繁體中文 香港 Sign in Before you continue to Google We use cookies and data, including IP addresses, to Deliver and maintain Google services Track outages and protect against spam, fraud, and abuse Measure audience engagement and site statistics to understand how our services are used and enhance the quality of those services If you choose to “Accept all,” we will also use cookies and data, including IP addresses, to Develop and improve new services Deliver and measure the effectiveness of ads Show personalized content, depending on your settings Show personalized ads, depending on your settings If you choose to “Reject all,” we will not use cookies or IP addresses for these additional purposes.
アトミックソフトウェア (AtomicSoftware Inc.)
AtomicSoftware develops and provides all-in-one SaaS solutions for various industries, including medical clinics and security companies. Their mission is to streamline complex operations and unlock the potential of niche industries through a multi-vertical SaaS approach. They build systems optimized for each industry's specific needs by combining small software components.
$3.8M Series c
today
GPN Vaccines
GPN Vaccines is a clinical-stage company focused on creating innovative vaccines that offer robust protection against the world's most important bacterial pathogens.
$10.0M Unknown
today
Largest funding rounds in Marketing on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  LIME Antigua and Barbuda | Unknown | $17.0B | 2y ago |
| 2 |  MOON-X Inc. Japan | Series c | ¥7.6B |
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Nanostine | Seed | $1.1M | today |
| 2 |  Guava United States | Seed | $12.5M | today |
Non-personalized content is influenced by things like the content you’re currently viewing, activity in your active Search session, and your location. Non-personalized ads are influenced by the content you’re currently viewing and your general location. Personalized content and ads can also include more relevant results, recommendations, and tailored ads based on past activity from this browser, l
Stemora, Inc.
Stemora is a preclinical-stage biotechnology company developing a one-step, disease-modifying regenerative therapy for osteoarthritis. The therapy activates the body's own skeletal stem cells to regenerate native hyaline cartilage, addressing the root cause of osteoarthritis rather than just managing symptoms. The company holds an exclusive worldwide license from Stanford University and is pursuing an FDA 505(b)(2) regulatory pathway.
$25.0K Unknown
today
| 2y ago |
| 3 |  Enthropic United States | Unknown | $5.0B | 1y ago |
| 4 |  Local Authorities United Kingdom | Unknown | £5.0B | 2y ago |
| 5 | Space Oddity United Arab Emirates | Unknown | $5.0B | 2y ago |
| 3 |
 Corridian United States |
| Seed |
| $38.0M |
| today |
| 4 |  Tallia United Kingdom | Seed | $4.5M | today |
| 5 | Vitroscope AS | Seed | $7.0M | today |
Trusted by 200+ sales teams
See who invested in Ploot and reach their contacts directly.
Start free trial
SuperIT
Recently received
Overfuel
Recently received
First Answer
Recently received
